Anna Moneymaker/Getty Images News Listen below or on the go on Apple Podcasts and Spotify. Former president says he is OK after rally shooting. (0:16) Netflix highlights earnings week. (1:39) Dividend calendar. (2:15) This is an abridged transcript: Donald Trump’s campaign says he is “fine” after what law enforcement officials are treating as an assassination attempt during a rally in Butler, Pennsylvania. The AP reports that officials said the man who opened fire was a 20-year-old from Pennsylvania. ...

What's better than a dividend? A dividend that's growing.Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields.Three Motley Fool contributors think they've found ideal dividend growth stocks to buy and hold. Here's why they picked AbbVie (ABBV 0.22%), Amgen (AMGN 1.77%), and Gilead Sciences (GILD -0.01%).Keeping a 52-year streak goingKeith Speights (A ...

The prices of these reliable dividend payers haven't kept pace with the frothy stock market.The broader stock market benchmarks keep reaching new heights, but the S&P 500 index's ongoing bull run has been driven heavily by its largest components. That means there are still plenty of reliable dividend-paying stocks that look like bargains.Shares of Johnson & Johnson (JNJ 0.12%), Agree Realty (ADC 0.63%), and AbbVie (ABBV 0.22%) offer enticing dividend yields at recent prices -- and they could raise their pay ...

Submissions are supported by the Phase 3 SELECT-GCA study demonstrating upadacitinib 15 mg with a 26-week steroid taper regimen achieved the primary endpoint of sustained remission from week 12 through week 521The safety profile of upadacitinib in patients with GCA was generally consistent with that in approved indications1NORTH CHICAGO, Ill., July 12, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted applications for a new indication to the U.S. Food and Drug Administration (FD ...

AbbVie (ABBV) stock has gained 24.0% compared with an increase of 34.3% for the industry in the past year, as seen in the chart below.Image Source: Zacks Investment ResearchAbbVie lost patent protection for its blockbuster immunology drug Humira in the United States in January 2023. Before it lost patent exclusivity, Humira accounted for a significant percentage of AbbVie’s sales, around 37% in 2022. Amgen (AMGN) was the first company to launch its Humira biosimilar. Thereafter, several other biosimilar ver ...

NORTH CHICAGO, Ill., July 10, 2024 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that Roopal Thakkar, M.D. who currently serves as senior vice president, chief medical officer, global therapeutics has been appointed to the position of executive vice president, research & development and chief scientific officer. In this position, Dr. Thakkar will lead the company's global R&D organization of more than 14,000 team members across all phases of discovery and development, including therapeutics and aesthet ...

Just 1% of all stocks listed on the major U.S. exchanges are Dividend Aristocrats. These are the 67 companies listed on the S&P 500 that have raised their dividends for 25 consecutive years or more. It is an elite group of stocks recognized for their quality and consistency over time.That doesn’t mean their shares won’t fall. In fact, many of the high-yield Dividend Aristocrats below are down in 2024 or have fallen over the past year. What separates them from other similarly situated stocks, though, is thei ...

Earnings Announcement - AbbVie will announce its Q2 2024 financial results on July 25, 2024, before the market opens [1] - The earnings conference call will be webcast live at 8 a.m. Central time and accessible via AbbVie's Investor Relations website [1] - An archived edition of the session will be available later on the same day [1] Company Overview - AbbVie's mission is to discover and deliver innovative medicines and solutions for serious health issues [2] - The company focuses on key therapeutic areas including immunology, oncology, neuroscience, and eye care [2] - AbbVie also offers products and services through its Allergan Aesthetics portfolio [2]

One of the most important sectors in any country’s economy is the biotech sector. Picking under-the-radar biotech stocks is easier said than done because we do not see immediate results. These companies have to move past the clinical trials and then prove that their drug or treatment is effective and safe.There are times when many of these candidates hit a dead wall, and the investment and research both go in vain. But if the company proves its worth, the rewards will be significant. This is why it takes a ...

Retirement stocks are something every investor needs to look into, and when deciding on which retirement stocks to buy, you can never go wrong with Dividend Kings, S&P 500 index constituents that have raised their dividends every one of the previous 25 straight years.Dividend growers had 11.7% compound annual returns from 1986 to 2016, while dividend payers had 9.9%. Dividend stocks are more resilient, so this outperformance is even greater during market volatility. This is great, since the markets are stil ...